CLL-1-SPEZIFISCHE ANTIKÖRPER

Patent europeic · EP2847222 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2847222
Numer da la dumonda
EP13787381
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
06-05-2013
Publitgà
18-03-2015
Concedì
26-09-2018
La protecziun finescha il pli tard
05-05-2033
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
C07K 16/28 (2006.01)
C07K 16/30 (2006.01)
Prioritad
US 201261643739 P 07.05.2012
US 201261699134 P 10.09.2012
US 201313794525 11.03.2013
Dumonda PCT
PCT/US2013/039645 06.05.2013
Publicaziun PCT
WO2013/169625 14.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  2. 28-11-2024

    Midada

    Published in Swissreg on 28.11.2024

  3. 31-10-2023

    Midada

    Published in Swissreg on 31.10.2023

  4. 15-08-2022

    Represchentant stritgà

    Representative
    VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (allontanà)

    Published in Swissreg on 15.08.2022

  5. 15-08-2022

    Transferì

    Owner
    Cellerant Therapeutics, Inc., 1561 Industrial Road, San Carlos, CA 94070, USA → ONK Therapeutics Limited, C/O Coll & Company, Pier Road, Barna Village, Co. Galway H91 V6KV, Ireland

    Published in Swissreg on 15.08.2022

  6. 26-09-2018

    Concedì

    Published in Swissreg on 26.09.2018

Partidas

Inventur

TRESSLER, Rob

San Carlos, CA 94070, US

KARSUNKY, Holger

San Carlos, CA 94070, US

JIANG, Ping

San Carlos, CA 94070, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.